| Literature DB >> 34866316 |
Xueting Xu1,2,3, Tanveer Ahmed2,3, Lulu Wang2,3, Xintao Cao4, Zeyu Zhang5, Ming Wang6, Yuan Lv2,7,8, Shahzina Kanwal2,8, Muqddas Tariq5, Runxia Lin2,3,7, Hui Zhang5, Yinghua Huang2,3, Hao Peng2,3,7, Danni Lin1,2,3, Xue Shi2,7, Didi Geng9, Baohua Liu6, Xiaofei Zhang2,5,7, Wen Yi9, Yan Qin4, Miguel A Esteban2,5,7,8,10,11, Baoming Qin2,3,5,7,11.
Abstract
Mouse embryonic stem cells (mESCs) can self-renew indefinitely and maintain pluripotency. Inhibition of mechanistic target of rapamycin (mTOR) by the kinase inhibitor INK128 is known to induce paused pluripotency in mESCs cultured with traditional serum/LIF medium (SL), but the underlying mechanisms remain unclear. In this study, we demonstrate that mTOR complex 1 (mTORC1) but not complex 2 (mTORC2) mediates mTOR inhibition-induced paused pluripotency in cells grown in both SL and 2iL medium (GSK3 and MEK inhibitors and LIF). We also show that mTORC1 regulates self-renewal in both conditions mainly through eIF4F-mediated translation initiation that targets mRNAs of both cytosolic and mitochondrial ribosome subunits. Moreover, inhibition of mitochondrial translation is sufficient to induce paused pluripotency. Interestingly, eIF4F also regulates maintenance of pluripotency in an mTORC1-independent but MEK/ERK-dependent manner in SL, indicating that translation of pluripotency genes is controlled differently in SL and 2iL. Our study reveals a detailed picture of how mTOR governs self-renewal in mESCs and uncovers a context-dependent function of eIF4F in pluripotency regulation.Entities:
Keywords: eIF4F; mTORC1; mitochondrial translation; pluripotency; self-renewal
Mesh:
Substances:
Year: 2021 PMID: 34866316 PMCID: PMC8811634 DOI: 10.15252/embr.202153081
Source DB: PubMed Journal: EMBO Rep ISSN: 1469-221X Impact factor: 8.807